Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02573493
Title Nab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Washington University School of Medicine
Indications

hypopharynx cancer

oropharynx cancer

head and neck squamous cell carcinoma

laryngeal squamous cell carcinoma

Therapies

Cisplatin + Nab-paclitaxel

Cetuximab + Nab-paclitaxel

Age Groups: adult
Covered Countries USA


No variant requirements are available.